ClinicalTrials.gg
RecruitingNCT07161050Updated Jan 16, 2026

Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing

An interventional study of Nicotine Content and Illegal cigarette price in Cigarette Smoking and E-cigarette Use, sponsored by Virginia Polytechnic Institute and State University. Recruiting at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-01-16.

Sponsored by Virginia Polytechnic Institute and State University · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Cigarette Smoking by Virginia Polytechnic Institute and State University — 3 open to participants now, 3 under way, none of them phase 3. Cigarette Smoking · Virginia Polytechnic Institute and State University.

Planned enrollment
9th of 15
70 · median 87
Started
2025
with 2 others
No phase
14 of 15
3 open now
Registered
15th of 15
by date

Among the 15 studies in Cigarette Smoking by Virginia Polytechnic Institute and State University, this one is the 9th largest by planned enrollment, is one of 3 that started in 2025, is one of 14 with no phase, and was the 15th registered.

Cigarette Smoking

477 studies on the registry are indexed under Cigarette Smoking; 87 are open to participants now.

Browse Cigarette Smoking studies →

Open to participants now

3 of the 15 studies in Cigarette Smoking by Virginia Polytechnic Institute and State University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 62 Cigarette Smoking studies recruiting now, 38 (61%) set no upper age limit and 18 (29%) stop at 75 or younger; 1 takes children under 18; 33 take healthy volunteers.

This study: 21 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Cigarette Smoking by Virginia Polytechnic Institute and State University, or all of them as a file.
02

Study summary

This study will investigate the effects of a very-low-nicotine cigarette (VLNC) standard, e-cigarette price, and illegal cigarette price on illegal product purchasing and alternative product use in a virtual marketplace.

Read the detailed description

This experiment will examine the effects of a VLNC standard, electronic cigarette price, and illegal cigarette price on illegal cigarette purchasing. Exclusive cigarette smokers and dual cigarette/nicotine vaping product (NVP) users, stratified by age, will complete multiple scenarios in the legal Experimental Tobacco Marketplace. The investigators will examine the effects of a VLNC standard, predicted to promote illegal purchasing. In the NNC conditions, participants' preferred normal nicotine content (NNC) cigarettes, NVPs, and a variety of other products will be available in the ETM, and preferred NNC cigarettes will also be available in the illegal marketplace. In the VLNC standard conditions, a ban will permit only VLNCs legally in the ETM, but preferred NNC cigarettes will continue to be available illegal marketplace. In this experiment, which will be completed in the lab, we will test three levels of NVP prices and three levels of illegal cigarette prices in scenarios under a VLNC standard or NNC condition. This study will involve a total of three sessions, including an assessment session, an ETM session, and a follow-up phone call.

03

Conditions studied

  • Cigarette Smoking
  • E-cigarette Use

Keywords

  • Experimental Tobacco Marketplace
  • Illegal cigarette
04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Provide Be at least 21 years of age or older Provide a breath sample for measuring carbon monoxide (CO ≥ 8 ppm) Stable tobacco use patterns for at least two months

Exclusion criteria

Exclusion Criteria:

For exclusive cigarette smokers:

Smoke at least 10 cigarettes daily and do not use NVPs regularly (no more than 9 times in the last month).

For dual cigarette/NVP users:

Smoke at least 10 cigarettes daily and use NVPs at least 3 times in a week (report use of closed nicotine salt system)

For both groups:

Have plans to move out of the area Have a serious or unstable physical or mental health condition Taking a tobacco cessation medication or medication that interferes with nicotine metabolism, motivation or reinforcement Report concrete, immediate plans to alter/quit using their usual nicotine products at the beginning of the study Being pregnant or lactating

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Exclusive cigarette smokers

    Exclusive cigarette smokers will be recruited and will be exposed to all of the conditions described in the intervention section.

    Behavioral: Nicotine Content · Behavioral: Illegal cigarette price · Behavioral: E-cigarette price

  • Experimental
    Dual cigarette/ nicotine vaping product users

    Dual cigarette and nicotine vaping product users will be recruited and will be exposed to all of the conditions described in the intervention section

    Behavioral: Nicotine Content · Behavioral: Illegal cigarette price · Behavioral: E-cigarette price

Interventions

  • BehavioralNicotine Content

    In the full nicotine conditions, participants' preferred cigarettes and NVP products will be available in the LETM and preferred cigarettes will be available in the iETM. In the low nicotine conditions, a ban will permit only VLNCs in the LETM and preferred cigarettes will be available in the iETM.

    Also known as: very-low nicotine standard

  • BehavioralIllegal cigarette price

    At each level of nicotine content, we will manipulate the price of illegal cigarettes (1xMP, 1.5x MP, 2x MP). MP is market price.

  • BehavioralE-cigarette price

    At each level of nicotine content and illegal cigarette price, we will manipulate the price of e-cigarettes (1xMP, 1.5x MP, 2x MP). MP is the market price.

06

What researchers measure

Primary outcomes

  1. Percent of budget allocated to each product category (eg, legal cigarettes, e-cigarettes, illegal cigarettes, etc) in the marketplace

    The investigators will measure the percent of each partcipants' study budget spent on products from each category (eg, legal cigarettes, e-cigarettes, illegal cigarettes, etc) in the marketplace

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Fralin Biomedical Research Institute at Virginia Tech Carilion
    Roanoke, Virginia 24016, United States
    Recruiting
    • Kirstin Gatchalian · Contactkmgatch@vtc.vt.edu · 540-526-2071
    • Roberta Freitas-Lemos, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No — The study team will share de-identified data upon request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Oct 2026, 10 months after the start.

Of 185 non-industry interventional studies with no phase under Cigarette Smoking, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 33. This study's planned 10 months is below that.

Counting every sponsor, half of 192 studies reached it within 20 months; a quarter within 8 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2025
First posted
Sep 8, 2025
StartActual
Dec 1, 2025
Primary completionEst.
Oct 1, 2026
CompletionEst.
Oct 7, 2026
Last update
Jan 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07161050
Responsible party
Roberta Freitas-Lemos (Assistant Professor, Virginia Polytechnic Institute and State University) — Principal investigator
First posted
Sep 8, 2025
Start date
Dec 1, 2025
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 7, 2026 (estimated)
Last update
Jan 16, 2026

Study contacts

Kirstin Gatchalian
Contact
kmgatch@vtc.vt.edu
540-526-2071
Madeleine Mason, PhD
Contact
mgmason@vtc.vt.edu
540-526-2114
Roberta Freitas-Lemos, PhD
principal investigator · Fralin Biomedical Research Institute at Virginia Tech Carilion

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion